384 related articles for article (PubMed ID: 15199806)
1. [Prognostic implication of morphometric stromal parameters of renal pelvis and ureteral transitional cell carcinomas].
Al'-Shukri CKh; Rybakova MG; Makovskaia AI; Tiurin AG; Kozlov VV; Ageev MN; Korneev IA
Urologiia; 2004; (3):10-4. PubMed ID: 15199806
[TBL] [Abstract][Full Text] [Related]
2. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
[TBL] [Abstract][Full Text] [Related]
3. [A clinical investigation on renal pelvic and ureteral tumors].
Okuno T; Hioki T; Kameda K; Satani H; Yamashita A; Sugimura Y; Tochigi H; Kawamura J; Tazima K
Hinyokika Kiyo; 1991 Aug; 37(8):851-6. PubMed ID: 1957727
[TBL] [Abstract][Full Text] [Related]
4. The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival.
Park J; Ha SH; Min GE; Song C; Hong B; Hong JH; Kim CS; Ahn H
J Urol; 2009 Sep; 182(3):894-9. PubMed ID: 19616243
[TBL] [Abstract][Full Text] [Related]
5. [Clinical studies on renal pelvic and ureteral carcinoma].
Akino H; Ishida H; Ito Y; Tanase K; Isomatsu Y; Muranaka K; Mori H; Kanamaru H; Okada K
Hinyokika Kiyo; 1997 Apr; 43(4):257-62. PubMed ID: 9161851
[TBL] [Abstract][Full Text] [Related]
6. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
Maulard-Durdux C; Dufour B; Hennequin C; Chrétien Y; Vignes B; Droz D; Delanian S; Housset M
J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
[TBL] [Abstract][Full Text] [Related]
7. [A clinical study of renal pelvic and ureteral cancer].
Kitsukawa S; Noda K; Hosoda S; Otsuru N; Matsumoto T; Yamamoto Y; Matsumoto T; Ito T
Hinyokika Kiyo; 2006 Nov; 52(11):829-34. PubMed ID: 17176863
[TBL] [Abstract][Full Text] [Related]
8. [Clinical observation on renal pelvic and ureteral tumors].
Miyagi T; Oshinoya Y; Shimamura M
Hinyokika Kiyo; 1990 Nov; 36(11):1261-6. PubMed ID: 2288306
[TBL] [Abstract][Full Text] [Related]
9. [Clinical studies on renal pelvic and ureteral tumors].
Yoshida T; Kajita Y; Iwaki H; Mori H; Yamauchi T
Hinyokika Kiyo; 2000 Feb; 46(2):77-81. PubMed ID: 10769793
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study on renal pelvic and ureteral tumors].
Okumura A; Yokoyama T; Muraishi Y; Nagakawa O; Sakamoto M; Kazama T; Fuse H; Katayama T
Hinyokika Kiyo; 1994 Sep; 40(9):777-80. PubMed ID: 7801838
[TBL] [Abstract][Full Text] [Related]
11. [A clinicopathological study on carcinoma of the renal pelvis and ureter].
Hashimoto H; Saga Y; Tokumitsu M; Yamaguchi S; Morikawa M; Yachiku S
Hinyokika Kiyo; 1997 Oct; 43(10):707-12. PubMed ID: 9395905
[TBL] [Abstract][Full Text] [Related]
12. [Retrospective analysis of uroepithelial malignancies detected in the renal pelvis and ureter over the past decade at the Jikei University Hospital].
Ikemoto I; Shimomura T; Yamada H; Kimura T; Hasegawa T; Abe K; Oishi Y
Hinyokika Kiyo; 2003 Aug; 49(8):451-6. PubMed ID: 14518380
[TBL] [Abstract][Full Text] [Related]
13. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL
BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
[TBL] [Abstract][Full Text] [Related]
14. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
Miyata Y; Kanda S; Nomata K; Hayashida Y; Kanetake H
Urology; 2004 Mar; 63(3):602-8. PubMed ID: 15028476
[TBL] [Abstract][Full Text] [Related]
15. [A clinical study on renal pelvic and ureteral cancer].
Sato E; Ishii A; Kunitomi K; Ishito N; Takamoto H; Araki T
Hinyokika Kiyo; 2002 Dec; 48(12):735-9. PubMed ID: 12613007
[TBL] [Abstract][Full Text] [Related]
16. [A clinical investigation on renal pelvic and ureteral tumors].
Nishimura K; Imazu T; Sakaue K; Yoshimura K; Miyoshi S; Mizutani S
Hinyokika Kiyo; 1992 Sep; 38(9):1009-13. PubMed ID: 1414751
[TBL] [Abstract][Full Text] [Related]
17. [Classification and prognosis of supravesical urothelioma with the new TNM classification].
Kühn R; Schafhauser W; Sigel A; Altendorf-Hofmann A
Urologe A; 1994 May; 33(3):247-51. PubMed ID: 8053094
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter.
Kamijima S; Tobe T; Suyama T; Ueda T; Igarashi T; Ichikawa T; Ito H
Int J Urol; 2005 Nov; 12(11):941-7. PubMed ID: 16351648
[TBL] [Abstract][Full Text] [Related]
19. [The prognostic value of KI-67 proliferation index in transitional cell carcinoma of renal pelvis and ureter].
Korneev IA
Vopr Onkol; 2005; 51(2):211-5. PubMed ID: 16223003
[TBL] [Abstract][Full Text] [Related]
20. [Clinical review of conservative management of upper urinary tract transitional cell carcinoma].
Oka H; Shiraishi Y; Negoro H; Iwamura H; Moroi S; Soeda A; Takeuchi H; Kawakita M
Hinyokika Kiyo; 2006 Apr; 52(4):249-53. PubMed ID: 16686350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
